Fenofibrate modulates cardiac energy metabolism in moderate-severe aortic stenosis: a mechanistic double-blinded randomised controlled MR trial

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Shveta Monga

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Severe aortic stenosis is associated with left atrial prothrombotic flow changes that persists despite successful aortic valve replacement

Doctor M. Spartera (Oxford, GB)

Abstract Slides Video

Presentation thumbnail

Right atrial and ventricular function in risk stratification of patients with pulmonary artery hypertension

Miss J. Guo (Sichuan, CN)

Abstract Slides Video

Presentation thumbnail

Impact of epicardial adipose tissue and atrial functional impairment in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

Doctor J. Gronwald (Goettingen, DE)

Abstract Slides Video

Presentation thumbnail

LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome

Doctor M. Lima (Lisbon, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Exploring valvular and congenital heart disease with cardiac magnetic resonance

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

When to use cardiac magnetic resonance in aortic stenosis

Congress Presentation

Dealing with technical and patient-related challenges in CMR: tips and tricks - discussion

Congress Presentation

Strategies for atrioventricular valve disease assessment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources